Equillium News

Equillium | 10-Q: Quarterly report

May 10 05:07

Equillium | 8-K: Equillium Reports First Quarter 2024 Financial Results and Provides Recent Clinical Highlights

May 10 04:12

Equillium | DEF 14A: Definitive information statements

Apr 12 04:12

Equillium | DEFA14A: Others

Apr 12 04:12

Equillium | ARS: Annual Report to Security Holders

Apr 12 04:11

Equillium | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Apr 2 05:09

Equillium | 8-K: Current report

Apr 1 20:11

Equillium | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 26 04:30

Equillium | 10-K: Annual report

Mar 26 04:16

Equillium | 8-K: Equillium Reports on Fourth Quarter and Full Year 2023 Financial Results and Corporate and Clinical Highlights

Mar 26 04:11

Equillium | 3: Initial statement of beneficial ownership of securities-Officer Tom Penny

Mar 9 06:37

Equillium | 8-K: Current report

Mar 9 05:02

Equillium | 8-K: Current report

Feb 24 06:20

Equillium | 424B5: Prospectus

Feb 24 06:16

Equillium | 8-K: Current report

Feb 22 19:11

Equillium | SC 13G: Statement of acquisition of beneficial ownership by individuals-Takeda Pharmaceutical Company Limited(5.2%),Takeda Ventures, Inc(5.2%)

Jan 19 13:00

Equillium | 4: Statement of changes in beneficial ownership of securities-Officer BRADBURY DANIEL

Jan 3 13:00

Equillium | 4: Statement of changes in beneficial ownership of securities-Officer Steel Bruce D.

Jan 3 13:00

Equillium | 4: Statement of changes in beneficial ownership of securities-Officer Connelly Stephen

Jan 3 13:00

Equillium | 4: Statement of changes in beneficial ownership of securities-Officer Rothman Joel

Jan 3 13:00